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Changes in Muscular Lipids in Unilateral
Isolated Hypertrophy of Gastrocnemius
Muscle Can Be Revealed by 
1H MR
Spectroscopy 
Objective: To test whether proton magnetic resonance spectroscopy (
1H-MRS)
reveals changes in the lipid content of the gastrocnemius muscle (GM) and
soleus muscle (SOL) of a patient with unilateral isolated hypertrophy of the right
GM. 
Materials and Methods: 
1H-MRS was performed on a 1.5 Tesla (T) whole-
body unit. Muscular lipids inside SOL and GM were assessed in both calves of
the patient by a STEAM (stimulated echo acquisition mode) localization
sequence. Results were compared to a control group of four healthy volunteers. 
Results: Total amount of muscular lipids in the hypertrophic GM of the patient
was clearly increased compared to the controls (38.7 versus 21.8±3.5 a.u.)
while intramyocellular lipids of the adjacent SOL were lower compared to the 
contralateral healthy leg.
Conclusion: Muscular lipids are substrates for metabolism and can be
assessed non-invasively by 
1H-MRS. 
1H-MRS is considered to be a helpful tool in
clinical assessment of muscle metabolism in cases with muscular hypo- or hyper-
trophy. 
egenerative and inflammatory processes in musculature often lead to
visible changes in standard T1- or T2-weighted magnetic resonance
images (MRIs) (1, 2). In addition, 
31P magnetic resonance spectroscopy
(MRS) has been established as a remarkable tool providing insight into mitochondrial
function and energy metabolism during exercise (3, 4). 
Proton magnetic resonance spectroscopy (
1H-MRS) is sensitive to small fractions of
lipids inside myocytes (intramyocellular lipids; IMCL) and adipocytes in fatty septa
between the muscle bundles (extramyocellular lipids; EMCL) (5-7). 
1H-MRS allows
higher spatial resolution (approximately 1 cm) than 
31P MRS (8). Due to the
anisotropic geometry of muscle fibres and fatty septa, 
1H-MRS is capable of distin-
guishing between the two different lipid compartments IMCL and EMCL (5-7).
However, this capability depends on the muscle fibre orientation with respect to the
outer static magnetic field.
In the past decade, research studies (human and animal) has proven that regulation
of muscular lipids (especially IMCL) is very complex and is dependent on internal
(e.g., genetics and muscle fibre composition) (9) and external (training, nutrition)
factors (10-12). Since the amount of muscular lipids is significantly increased in
subjects with reduced insulin sensitivity and with a tendency towards developing type
two diabetes and/or metabolic syndrome (13, 14), muscular (and hepatic) lipid
measurement by 
1H-MRS is under investigation in many ongoing metabolic and
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Dendocrinology-oriented studies. 
Most exercise studies suggest that IMCL play a major
role as an energy supply in aerobic states (15, 16), as
prolonged moderate exercise can decrease IMCL within
hours (15). In addition, there is evidence that well trained
athletes show a higher storage of muscular lipids in resting
muscle compared to normal, untrained subjects (17).
The aim of this case study was to use the highly sensitive
1H-MRS to determine pathologic changes in muscle
metabolites of isolated muscle hypertrophy. This case
allowed us to examine muscular lipids in isolated hypertro-
phy of the medial portion of the gastrocnemius muscle
(GM) without any conspicuous signal changes of muscula-
ture in MRI. Both agonistic muscles, the GM, and the
soleus muscle (SOL) were examined on the affected right
side and on the normal left side of the patient by standard
MRI and by volume localized 
1H-MRS. The results were
compared with a control group comprised of four healthy
volunteers.
SUBJECTS AND METHODS
Patient Data
Four years prior to the 
1H-MRS study a 13-year-old girl
suffered from an abscess on the back of her right knee,
which was then therapeutically drained. A small scar from
this procedure remains. Two years later, the patient was
referred to our hospital for the first time with a non-
inflamed swelling of the right calf. Conventional MRI with
T1- and T2-weighted sequences and magnetic resonance
angiography did not indicate any tumor or hemangioma,
but an enlargement of the medial portion of the right GM
was clearly depicted (Fig. 1), accompanied by a slight
augmentation of the lateral portion. Clinical examination
did not show significant differences between the legs
concerning muscular strength or the pattern of reflexes.
Electrophysiological examinations of the right GM did not
reveal neurological deficits of this muscle. After all, a
larger circumference of 3 cm of the right calf was stated
compared to the left side, interpreted as muscular
hypertrophy. Partial denervation or irritation of related
branches of the tibialis nerve due to the former abscess and
its treatment was supposed to be the reason for the
hypertrophy of the GM. A muscle biopsy was not
performed due to normal morphology and a lack of
muscular dysfunction.
For assessment of muscular lipids under these specific
pathologic conditions, a combined MRI and 
1H-MRS
examination was performed after informed consent by the
patient and her parents. The aim of the examination was to
evaluate whether there is any substantial local effect on the
lipid stores in the affected muscle and its agonist.
Healthy Volunteers
The results of the patient were compared to the data
from both calves of four healthy young (age 30-35 years)
volunteers without any history of metabolic or muscular
diseases. All subjects gave written consent, and the studies
were approved by the local Ethics Committee of the
University School of Medicine.
MRI and 
1H-MRS
MR examinations were performed on a 1.5 Tesla whole-
body system (Magnetom Vision; Siemens, Erlangen,
Germany). In both legs two muscles of the calf were
examined: the SOL and the medial portion of the GM,
both being functional agonists and muscles with high
oxidative capacity. Standard multi-planar T1- and T2-
weighted imaging allowed assessment of possible changes
in muscular signal characteristics and of hyper- or hypotro-
phy. Positioning for localized 
1H-MRS was performed on
the T1-weighted images as indicated in Figure 1. Localized
1H spectra with a voxel size of 2.4 cm
3 were recorded from
representative regions in the muscles using the standard
extremity coil for radiofrequency excitation and signal
recording. The region of interest (ROI) was positioned in
the central part of the muscles in order to avoid contribu-
tions from macroscopic fatty layers between the muscle
groups and field distortions due to large vessels or bony
structures. It is known from chemical shift imaging (CSI)
examinations that the IMCL level tends to be rather
homogeneous inside a specific muscle while EMCL contri-
butions show more variations for changed ROI position
(18). Volume selective shimming was performed for each
Brechtel et al.
582 Korean J Radiol 10(6), Nov/Dec 2009
Fig. 1. Axial T1-weighted image of lower legs performed in 13-
year-old girl with unilateral hypertrophy of right calf. Right medial
gastrocnemius muscle is hypertrophic, lateral portion shows slight
augmentation. White boxes indicate voxel positions for spectro-
scopic examinations. A = right medial gastrocnemius muscle
(GM), B = left GM, C = right soleus muscle (SOL), D = left SOL.new voxel position. Spectra were recorded using a
stimulated echo acquisition mode (STEAM) technique with
TR = 2 s / TE = 10 ms / TM = 15 ms and with frequency
selective water suppression. The recorded signals
underwent common post-processing procedures, which
included the following: Gaussian filtering with maximum at
0 ms and half maximum after 150 ms, Fourier transforma-
tion, constant and linear phase correction. For both, SOL
and GM muscles, total muscle lipids (TML) were measured
as the area under the signal curve in fixed frequency
borders (TML; 1.3-1.8 ppm, covering all methylene
signals). In addition, the methyl creatine signal (3.05-3.25
ppm; maximum signal set to 3.15 ppm) was calculated for
each spectrum. Since fibre orientation in GM leads to
overlapping signals from IMCL and EMCL, separate IMCL
values could only be determined for SOL (frequency
borders: 1.3-1.5 ppm), where both signal portions were
distinguishable in the spectrum. TML and IMCL values are
given as signal ratios between the integral lipid signals and
the integral of the creatine signal.
Unilateral Isolated Gastrocnemius Muscle Hypertrophy and Lipid Changes in 
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Fig. 2.
1H-MRS of right (A) and left (B)
GM and right (C) and left (D) SOL
performed in 13-year-old girl with unilat-
eral hypertrophy of right calf. Signals are
indicated in C as Chol (choline; 3.4
ppm), Crea (creatine; 3.15 ppm), IMCL
(intramyocellular lipids; 1.3-1.5 ppm),
and EMCL (extramyocellular lipids; 1.5-
1.7 ppm). Spectra are referenced on
creatine signal of each muscle. Signal
intensities are given in arbitrary units as
usual in 
1H-MRS. GM = gastrocnemius
muscle, SOL = soleus muscle
AB
CDValues in the control group were compared by a
Student’s t-test after passing a normality test. Differences
were considered to be statistically significant if p < 0.05.
RESULTS
Patient
A transverse T1-weighted image of the patient’s lower
legs is depicted in Figure 1 indicating an enlarged transsec-
tion area of approximately 50% of the right GM when
compared to the left side. Other muscles of the lower leg
do not show any remarkable difference in size or morphol-
ogy when compared to the left side. 
When the same calibration of the MR system (coil
system, transmitter, receiver, signal calibration, post-
processing) was applied, integral values of the creatine
signals at 3.15 ppm of both muscles, the SOL and the GM,
did not reveal any remarkable side differences (SOL: 34.0
versus 32.0 a.u.; GM: 22.4 versus. 23.9 a.u.). The 
1H-
spectra indicate a TML in the left GM of 24.0 and a clearly
higher content of 38.7 in the right hypertrophic GM
(integral lipid values referenced by integral of creatine in
the same spectrum) (Fig. 2A, B). The spectra from the GM
showed high quality (narrow line width), but did not allow
the separation of IMCL and EMCL signals, due to the
unfavourable orientation of the muscle fibres with respect
to the static magnetic field. The lateral portion was not
investigated due to the flat shape of the muscle and the
artefacts expected in 
1H-spectra when the voxel would be
positioned too close to the subcutaneous fatty tissue (Fig.
1).
In contrast, 
1H-spectra of SOL clearly distinguish
between EMCL and IMCL signals (Fig. 2C, D). Those
spectra show a difference in IMCL between the right and
the left leg of the patient: IMCL content of the right SOL -
the same side as the hypertrophy of GM - is clearly lower
compared to the left SOL (9.2 versus 14.7).
Control Group
In the control group no remarkable intra-individual
differences in the circumferences of the legs were found.
Individual creatine values were similar for the left and
right calf (SOL: 32.9 ± 1.6 versus 35.4 ± 1.5, p = 0.1;
GM: 25.8 ± 1.8 versus 29.0 ± 1.8, p = 0.3). 
Table 1 summarizes the TML data in the control group
and indicates also comparatively moderate side differ-
ences: for SOL the TML values of the normal controls
revealed no significant difference between both sides (18.4
± 3.0 versus 17.0 ± 2.8; p = 0.5). 
Patient versus Control group
Total muscle lipid values of the patient’s SOL muscles
(19.3 and 18.2) were within the range of the control group.
For the GM the patient presented a TML of 24.0 for the left
side that was within the normal range, but a clearly higher
value of 38.7 for the hypertrophic right GM (Table 1).
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Table 1. Comparison of TML Values of Healthy Controls and of Patient with Hypertrophy of Right GM
Subject No.
TMLSOL (a.u.) TMLGM (a.u.) TML-Ratio
Left Right Left Right Left Right
1 11.2 11.3 16.9 16.9 1.50 1.49
2 25.6 23.7 26.7 19.7 1.05 0.83
3 19.4 13.4 14.9 11.8 0.77 0.88
4 17.4 19.6 28.7 25.6 1.65 1.31
Mean ± SEM 18.4 ± 3.0 17.0 ± 2.8 21.8 ± 3.5 18.5 ± 2.9 1.24 ± 0.20 1.13 ± 0.16
Hypertrophy patient 19.3 18.2 24.0 38.7 1.24 2.12
Note.─ Total muscle lipid values of soleus (TMLSOL) and of medial portion of gastrocnemius muscle (TMLGM) are given for left and right leg. 
TML-ratios = TMLGM/TMLSOL are included for both sides. GM = gastrocnemius muscle, SEM = standard error of mean
Fig. 3. Comparison of total muscle lipid ratio between gastrocne-
mius muscle and soleus muscle, for normal controls (white
diamonds) and patient (grey hexagons). Mean value of normal
controls is indicated as black dot with 95%-intervals as error bars.
Total muscle lipid-ratio of patient’s right leg (with gastrocnemius
muscle hypertrophy) is clearly above normal range. TML = total
muscle lipidTo proof the relation between the muscular lipid content
of the agonistic GM and SOL, TML-ratios were calculated
(TML-ratio = TMLGM/TMLSOL) for each leg. For the
patient’s hypertrophic right leg the TML-ratio amounted to
2.1 (versus 1.13 ± 0.16 in the control group) (Fig. 3)
(Table 1). TML-ratio of the (unaffected) left leg of the
patient was in the middle range of the normal controls
(1.24 versus 1.24 ± 0.20) (Fig. 3) (Table 1). 
DISCUSSION
Muscle pathologies are diagnostically accessible by MR
techniques. As shown in multiple MRI studies, certain
muscular pathologies show specific changes in MR images
(19). MR imaging characteristics of denervated
hypertrophic musculature can include excessive amounts
of interspersed fatty septa within the muscle (19-22). For
true hypertrophy, Petersilge et al. (19) only found an
isointense enlargement of the muscle, but spectroscopy
was not performed to investigate the EMCL and IMCL
content. Narayana et al. (23) earlier described spectro-
scopic changes of the total lipid signal in hypertrophied
muscle undergoing botulinum toxin therapy. It should be
noted that spectral quality and the aspect of the two differ-
ent lipid compartments was not given at that time. 
The case presented in our study was diagnosed as
paradoxical hypertrophy with neurogenic origin based on
clinical history even though other subjective supportive
clinical data were absent. Inflammatory and dystrophic
muscular diseases were excluded by clinical history and
functional tests as well. There were no typical patterns
revealing systemic muscular disease or pathological blood
test showing increased creatinine kinase levels. On clinical
database and conventional MRI, this pathologic case can be
considered as both true hypertrophy and pseudohypertro-
phy of neurologic origin (19, 23). By performing 
1H-MRS
signals of muscular lipids can be assessed and distinguished
more clearly. True hypertrophy of skeletal muscle leads to
a different composition of intracellular metabolites because
the increase in muscle mass demands energy substrates
such as IMCL (15, 17, 18). In our case, the hypertrophic
GM on the right side showed an elevated TML content
while its agonistic ipsilateral SOL did not show significant
differences in total muscular lipids, but lowered IMCL
when compared to the left side. Side differences in four
healthy volunteers serving as controls were less
pronounced compared to the patient. 
However, there is an age difference between the patient
and the controls. It is known from the literature on
localized 
1H-MRS of musculature in vivo and from our
experience with several hundreds of examinations in
metabolic studies that 
1H-MRS spectra of skeletal muscula-
ture show only minor age dependences (mainly with
slightly increased fractions of EMCL in the elderly).
Furthermore, the normal leg of the patient shows signal
patterns in the spectra which are very similar to the
controls (Table 1). An aged-matched group could not be
investigated due to ethical concerns.
The increased total lipid signal of the right hypertrophic
GM cannot unambiguously be attributed to IMCL or
EMCL since fibre orientation of this muscle in relation to
the B0 field (parallel to the body axis) led to markedly
superimposed signal contributions in the spectrum.
Compared to SOL, fibres in GM are more angulated with
respect to the B0 (magnetic field strength), resulting in a
lower separation of the lipid fractions as demonstrated by
Boesch et al. (6). On the other hand, since there are no
signs of fatty degeneration or increased amount of fatty
septa of this muscle in conventional imaging, the measured
extremely high TML level in the hypertrophic muscle is
most probably due to an increased amount of IMCL in this
muscle. Since there was no neurological deficit of the right
GM on electrophysiological examination, hypertrophy of
GM and the increased level of lipids in this muscle can be
interpreted as a result of muscle training. The reason might
be the irritation of the tibialis nerve resulting in a modifica-
tion of the electrical stimulation pattern of this muscle
resulting in increased activity of this muscle and consecu-
tively to higher storage of lipids within the muscle cell. The
agonistic right SOL performed less physical activity leading
to a decreased muscular lipid content compared to the
contralateral SOL. This interpretation would be in
accordance to a study of Zehnder et al. (17) who found a
higher IMCL content in muscles of well-trained subjects. 
To our knowledge this is the first clinical case of isolated,
externally induced hypertrophy of a muscle in which 
1H-
MRS was performed to quantitatively assess muscular lipid
content. In musculature with fibre orientation nearly along
the body axis (and along the applied outer magnetic field)
even separate determination of metabolically highly active
IMCL and less active EMCL is possible (5, 6, 10). In
conclusion, 
1H-MRS could be helpful in the assessment of
muscle metabolism in cases with partial denervation or
nerve irritations. Follow-up studies with 
1H-MRS could
become a tool for monitoring the success of therapeutic
interventions.
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